Laboratory Services

 

Metropolis buys big in India, targets further growth

India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.

Biogroup ‘buying’ €100m French lab

France's largest lab group Biogroup is reportedly continuing its consolidation of the French market and in exclusive negotiations to acquire much smaller competitor Oriade Noviale.

Denmark tenders €200m lab services for COVID-19

The Danish regions want to spend just over €201m on collection and analysis services for COVID-19 PCR and antigen tests. This is more than 13x what the market's largest players - Unilabs and Synlab - earnt in the market in 2019.

HBI 2020: GDPR kills off international competition for genetic tests

GDPR made it much harder to send samples outside Europe for genetic testing, the director for genetics at Europe's largest lab group Synlab told HBI 2020 delegates. He went through the basics of running a genetic lab business, including workforce, payors and the main challenges.

HBI 2020: Non-COVID lab volumes recover in Q3 but M&A model may be redundant

Non-COVID lab volumes reached their pre-pandemic levels in Q3. But does the pandemic signal the end of the sector's reliance on M&A, and what are the implications of new B2C markets? Operators Unilabs, amedes, Medicover and Dr Lal Pathlabs, B2C platform Daslab and supplier Abbott discussed all this and more at HBI 2020's 'Diagnostics: Opportunities and Challenges' & 'A new global consumer market?' sessions.

HBI 2020: Investor interest in hospitals increases while outpatient valuations drop

Investors from varied backgrounds - infrastructure, private equity, and REIT, are all bullish about the prospects for healthcare investment in 2021, according to a panel of experts speaking at the HBI 2020 European Investment Panel discussion. But the pandemic may have 'readjusted the relative value discussion across sectors' according to one private equity investor.

HBI 2020: Medtech and services – new partnerships and opportunities

The relationship between medtech and its customers is changing. No longer is medtech wheeled out for a one-off purchase. Long-term partnerships are being built, and patients and providers are benefitting. An expert panel at HBI 2020 explored the burgeoning relationship between medtech and services, and some of the challenges this presented.

Interview: Klaus Boehncke, Partner, L.E.K. Consulting 

What can you do with AI and big data today and what will be possible within three years? Why has adoption been slower than you might have expected? And what sort of role should health care providers look to play? HBI gets an expert view from digital, technology and business strategy expert Klaus Boehncke, partner at L.E.K. Consulting, who is chairing the Best Practice Workshop: Delivering Digital Excellence: A Framework for Success at HBI 2020 in two weeks.

CEE – a land of opportunity?

With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.

Find Us